Además de la miocardiopatía hipertrófica, existen una serie de enfermedades o miocardiopatías que se asocian con hipertrofia ventricular izquierda. Por ello, me gustaría recomendar los siguientes artículos:
- Frey N, Luedde M and Katus HA. Mechanisms of disease: hypertrophic cardiomyopathy. Nat Rev Cardiol 2012;9:91-100.
- Force T, Bonow RO, Houser SR, et al. Research priorities in hypertrophic cardiomyopathy. Report of a working group of the National Heart, Lung, and Blood Institute. Circulation 2010;122:1130-1133.
- Cikes M, Sutherland GR, Anderson LJ, Bijnens BH. The role of echocardiographic deformation imaging in hypertrophic myopathies. Nat Rev Cardiol 2010;7:384-396.
- Morita H, Seidman J, Seidman CE. Genetic causes of human heart failure. J Clin Invest 2005;115:518-526.
- Van der Ploeg AT, Reuser AJJ. Pompe’s disease. Lancet 2008;372:1342-1353.
- Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005;352:362–372.
- Maron BJ, Roberts WC, Arad M, et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyophaty. JAMA 2009;301:1253-1259.
- Carbone I, Francone M, Chimenti C, et al. Right ventricular late enhancement as a magnetic resonance marker of glycogen storage disease. Circulation 2010;122:189-190.
- Zarate YA, Hopkin RJ. Fabry’s disease. Lancet 2008;372:1427-1435.
- Moon JCC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24: 2151–2155.
- De Cobelli F, Esposito A, Belloni E, et al. Delayed-enhanced cardiac MRI for differentiation of Fabry’s disease from symmetric hypertrophic cardiomyopathy. AJR 2009;192:W97-W102.
- Fernández-Vizarra E, Bayona-Bafaluy MP, Enríquez JA. Cardiopathies of mitochondrial origin. Nat Rev Cardiol (CNIC Edition) 2010;7: 47-53.
- Conceição Silva M, Alves Meira ZM, Gurgel Giannetti J, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 2007;49;1874-1879.
- Yilmaz A, Gdynia H-J, Ludolph AC, et al. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son. Similar pattern revealed by cardiovascular MRI. Circulation 2010;121:e237-e239.
- Aoki Y, Niihori T, Narumi Y, et al. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 2008;29:992-1006.
- Lehmann LH, Schaeufele T, Buss SJ, et al. A patient with Leopard syndrome and PTPN11 Mutation. Circulation 2009;119:1318-1329.
- Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005;112: 2047-2060.
- Syed IS, Glockner JF, Feng D, et al. Role of Cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. J Am Coll Cardiol Img 2010;3:155-164.
- Rapezzi C, Quarta CC, Riva L, et al. Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 2010;7:398-408.
